Boryung Explains Reason for OTC Price Increases

Published: 2005-03-11 06:56:00

Updated: 2005-03-11 06:56:00

In response to an industry report that Boryung Pharmaceutical is increasing prices for certain over-the-counter (OTC) products with established market recognitions, the company explained that the decision is not reflective of an intention to solely assume the profits without due considerations to...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK